HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Operating Expenses (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Operating Expenses came in at -$156.3 million in Q2 2021, down 54.99% year-over-year from -$347.4 million in Q2 2020, and down 8.0% quarter-over-quarter from -$144.8 million in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Operating Expenses (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Operating Expenses for 4 consecutive years, with -$156.3 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Operating Expenses fell 54.99% year-over-year to -$156.3 million in Q2 2021; TTM through Jun 2021 was -$486.0 million, a 34.26% decrease from a year earlier, with the FY2025 full-year figure at -$587.7 million, up 12.8% from the prior year.
  • Operating Expenses was -$156.3 million for Q2 2021 at HUTCHMED (China), down from -$144.8 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $233.2 million in Q2 2018 and troughed at -$262.4 million in Q2 2019.
  • A 4-year average of -$44.2 million and a median of -$84.7 million in 2019 frame the typical range for Operating Expenses.
  • The widest YoY moves for Operating Expenses: up 214.04% in 2019, down 218.76% in 2019.
  • Over 4 years, Operating Expenses stood at $77.3 million in 2018, then plunged by 218.76% to -$91.8 million in 2019, then fell by 9.9% to -$100.9 million in 2020, then sank by 54.99% to -$156.3 million in 2021.
  • The last three Operating Expenses figures came in at -$156.3 million (Q2 2021), -$144.8 million (Q1 2021), and -$100.9 million (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 212.20 Bn 198.21 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 181.83 Bn 178.65 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 132.47 Bn 124.61 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 82.56 Bn 74.56 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 61.59 Bn 56.40 Bn 1.37 Bn -1.05 Bn
6 Moderna 54.65 Bn 49.51 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.42 Bn 30.13 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 30.21 Bn 30.21 Bn 1.16 Mn 367.83 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -156.34 Mn
Mar 31, 2021 -144.76 Mn
Jun 30, 2020 -100.87 Mn
Mar 31, 2020 -84.06 Mn
Dec 31, 2019 -91.78 Mn
Sep 30, 2019 -85.29 Mn
Jun 30, 2019 -262.43 Mn
Mar 31, 2019 88.22 Mn
Dec 31, 2018 77.28 Mn
Sep 30, 2018 73.60 Mn
Jun 30, 2018 233.23 Mn
Mar 31, 2018 -77.36 Mn